GENETIC AND HISTOLOGICAL STUDIES ON EFFECT OF MESENCHYMAL STEM CELL THERAPY ON EXPERIMENTAL RENAL INJURY INDUCED BY CISPLATIN IN MALE ALBINO RATS
*Rokaya H.Shalaby, Laila A.Rashed, Alaa E.Ismail, Naglaa K.Madkour and
Sherien H.Elwakeel
ABSTRACT
Acute kidney injury (AKI) represents a major clinical problem with
high mortality and limited treatment protocols. This study was planned
to evaluate the therapeutic effectiveness of bone marrow – derived
mesenchymal stem cells (BM-MSCs) in a rat model of cisplatininduced
AKI. The aim of the present investigation is to determine
whether mesenchymal stem cells can restore renal tubular structure and
ameliorate cisplatin-induced clastogenesis in the bone marrow cells of
rat. The scoring of chromosomal aberrations was undertaken in the
current study as markers of clastogenicity. The Study was carried on
36 male white albino rats, of average weight 120-150 gm. The animals were divided into six
groups, Group one: - Served as control and received normal saline throughout the
experiments. Group two (model control) received a single dose of cisplatin (5 mg/kg
interapritoneally) after 5 days. Group three, four, five and six: - Male albino rats with induced
ARF received single interapritoneal injection of PKH26 labeled BM-MSCs immediately after
induction of renal failure at different time intervals. Serological measurements included
serum urea and creatinine, bone marrow preparation for chromosome aberrations were
carried out and kidney specimens were processed for H&E. MSCs-treated group exhibited
protection against renal injury serologically and histologically. The main result obtained in
the present study revealed that cisplatin when given at a single dose of 5 mg/kg cause high
incidences of the percentage of total chromosomal aberrations 62.33% and abnormal
metaphases in the bone marrow cells of rat. This percentage was reduced nearly to 17.33% after injection with mesenchymal stem cells for 30 days, the reduction was highly significant
(P
Keywords: Acute renal failure; chromosome; cisplatin; mesenchymal stem cells; Renal regeneration.
[Download Article]
[Download Certifiate]